Risk of hypertension in patients newly diagnosed with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and treated with covalent Bruton tyrosine kinase inhibitors (cBTKi): A real-world study.

Authors: Ayad K. Ali, Lili Zhou, Jamie Colasurdo, Wassim Aldairy, Qianhong Fu, Nicole Lamanna

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23334

Source: Full article

e23334